These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 17040248)
1. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. Satoh H; Kurishima K; Ishikawa H; Ohtsuka M J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901 [TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders]. Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986 [TBL] [Abstract][Full Text] [Related]
4. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases]. Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675 [TBL] [Abstract][Full Text] [Related]
5. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818 [TBL] [Abstract][Full Text] [Related]
7. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis. Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311 [TBL] [Abstract][Full Text] [Related]
8. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. Kohno N J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309 [TBL] [Abstract][Full Text] [Related]
9. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia]. Kobayashi J; Itoh Y; Kitamura S; Kawai T Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of interstitial pneumonia following surgery for lung cancer. Takeda S; Maeda H; Sawabata N; Kitada S; Mori M; Takashima S; Matsubara Y Thorac Cardiovasc Surg; 2006 Jun; 54(4):268-72. PubMed ID: 16755450 [TBL] [Abstract][Full Text] [Related]
11. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis]. Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528 [TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia]. Kohno N Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213 [TBL] [Abstract][Full Text] [Related]
13. Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome. Kase S; Kitaichi N; Namba K; Miyazaki A; Yoshida K; Ishikura K; Ikeda M; Nakashima T; Ohno S Am J Kidney Dis; 2006 Dec; 48(6):935-41. PubMed ID: 17162148 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of KL-6 are positively correlated with those of CA15-3 in patients with interstitial pneumonia associated with collagen diseases. Okada M; Suzuki K; Nakanishi T; Nakashima M Respirology; 2006 Jul; 11(4):509-10. PubMed ID: 16771927 [No Abstract] [Full Text] [Related]
15. Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma. Xu H; Inagaki Y; Tang W; Guo Q; Wang F; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M Hepatogastroenterology; 2008; 55(88):2000-4. PubMed ID: 19260467 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696 [TBL] [Abstract][Full Text] [Related]
17. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases]. Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of the serum KL-6 assay in patients with hepatitis C virus. Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H Intervirology; 2005; 48(6):400-4. PubMed ID: 16024944 [TBL] [Abstract][Full Text] [Related]
19. [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D]. Nakamura M; Ogura T; Miyazawa N; Tagawa A; Kozawa S; Watanuki Y; Takahashi H Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):455-9. PubMed ID: 17644940 [TBL] [Abstract][Full Text] [Related]
20. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients. Hu Y; Wang LS; Jin YP; Du SS; Du YK; He X; Weng D; Zhou Y; Li QH; Shen L; Zhang F; Su YL; Sun XL; Ding JJ; Zhang WH; Cai HR; Dai HP; Dai JH; Li HP Clin Respir J; 2017 May; 11(3):337-345. PubMed ID: 26077281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]